Hepatotoxicity functions in Foxa2 direct targets identified by IPA included highly enriched “liver hyperplasia” (p‐value 1.75 × 10−16) and “liver steatosis” (p‐value 1.80 × 10−6) (Figure 4b). Here, FOXA2 is linked to fatty liver disease.